Molecular markers prognostic for biochemical failure in prostate cancer
This article has no abstract so we have provided the first paragraph of the full text.
Although there are established prognostic markers for prostate cancer, such as the Gleason score and serum concentration of prostate-specific antigen, these markers do not accurately predict the variation in outcome seen in patients with this disease. Vergis et al. evaluated molecular markers of hypoxia and angiogenesis that might better predict outcome in prostate cancer.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.